Application of laboratory tests in the diagnosis and treatment of hepatitis C

doi:10.3969/j.issn.1673-8640.2014.10.021

Abstract

Abstract:

Hepatitis C virus (HCV) infection has become one of the serious public healthy problems, and it is estimated that about 170 to 200 million people infect with HCV around the world. The number of infections in China has exceeded 40 million, accounting for a quarter of the world's number. The related mortalities including hepatic decompensation and hepatocellular carcinoma will also increase dramatically during the next 20 years in the future. HCV mutates more frequently than hepatitis B virus (HBV). Therefore, no protective vaccine is presently available for HCV in clinic. For this reason, diagnosing active HCV infection will be crucial to slowing its spread. In this review, we discuss laboratory tests used for screening HCV infection, as well as for patient efficiency monitoring.

Key words: Hepatitis C virus, Diagnosis, Treatment, Laboratory test

CLC Number:

R373.2

GUO Wei，PAN Baishen.. Application of laboratory tests in the diagnosis and treatment of hepatitis C[J]. , 2014, 29(10): 1069-1073.

References

[1] Williams R. Global challenges in liver disease[J]. Hepatology,2006,44(3): 521-526.
[2] Davis GL,Albright JE,Cook SF,et al. Projecting future complications of chronic hepatitis C in the United States[J]. Liver Transpl,2003,9(4): 331-338.
[3] Halliday J,Klenerman P,Barnes E. Vaccination for hepatitis C virus: closing in on an evasive target[J]. Expert Rev Vaccines,2011,10(5): 659-672.
[4] Simmonds P,Holmes EC,Cha TA,et al. Classification of hepatitis C virus into six major genotypes and a series of subtype by phylogenetic analysis of the NS-5 region[J]. J Gen Virol, 1993,74(Pt 11): 2391-2399.
[5] 中华医学会检验分会,卫生部临床检验中心,中华检验医学杂志编辑委员会.肝脏疾病诊断治疗中实验室检测项目的应用建议[J]. 中华检验医学杂志,2013,36(9): 773-784.
[6] Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965[J]. MMRW Recomm Rep,2012,61(RR-4): 1-32.
[7] Ge D, Fellay J,Thompson AJ,et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance[J]. Nature,2009,461(7262): 399-401.
[8] 方超萍,孙薇薇,孙小波,等. 丙型肝炎患者不同病毒载量与病毒学应答及肝功能改变的相关性[J]. 现代检验医学杂志,2012,27(5):18-21.
[9] McHutchison JG,Everson GT,Gordon SC,et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection[J]. N Engl J Med,2009,360(18): 1827-1838.
[10] Poynard T,Marcellin P,Lee SS,et al. Randomised trial of interferon alpha 2b and ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)[J]. Lancet,1998,352(9138): 1426-1432.
[11] Davis GL,Lau JY. Factors predictive of a beneficial response to therapy of hepatitis C[J]. Hepatology,1997,26(3 Suppl 1): 122S-127S.
[12] Dienstag JL,McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C[J]. Gastroenterology,2006,130(1): 231-264.

[1]	WANG Huiying, TANG Yu, DONG Lili, WANG Jing. Role of Mycoplasma pneumoniae RNA determination in diagnosis and efficacy monitoring of pneumonia in children [J]. Laboratory Medicine, 2023, 38(9): 865-869.
[2]	SUN Xinlin, YE Xingming, LI Qian, ZHAO Lijun. Bronchoscopy combined with sputum Mycobacterium tuberculosis ribonucleic acid and serum Mycobacterium tuberculosis specific antibody determinations for diagnosis of negative pulmonary tuberculosis [J]. Laboratory Medicine, 2023, 38(9): 870-873.
[3]	HAN Xue, WEN Liu, WAN Yang. Analysis of amniotic fluid chromosome karyotype and genome copy number variation in critical or high-risk pregnant women by Down's screening [J]. Laboratory Medicine, 2023, 38(6): 548-552.
[4]	ZHANG Chu, WANG Jianhong, LI Rui, XIAO Yanhua, WANG Heng, ZHANG Pinxiao, XU Ningxin, XIA Banban. Results of non-invasive prenatal testing-plus in 5 696 pregnant women [J]. Laboratory Medicine, 2023, 38(6): 553-558.
[5]	WU Youhong, SONG Yunxiao, ZHU Yong, GE Wen, BIAN Xiaobo, YUAN Wenhua, ZHAO Zhiyun. Role of blood lipid levels in assessment of coronary artery stenosis and its treatment in patients with coronary heart disease [J]. Laboratory Medicine, 2023, 38(6): 584-589.
[6]	ZHANG Min, WANG Binyu, CHI Weiqun, LIU Yu. Research progress of exosomal non-coding RNA as biomarkers for disease diagnosis [J]. Laboratory Medicine, 2023, 38(6): 594-598.
[7]	ZHANG Guoliang, LIU Yiwen, HE Yiqing, XU Jing, YANG Cuixia, GAO Feng, LIU Hua. Roles of serum HYAL1 and HA in the auxiliary diagnosis and therapeutic monitoring of colorectal cancer [J]. Laboratory Medicine, 2023, 38(4): 313-319.
[8]	CHEN Zhe, ZHANG Ling, LIU Jie, WANG Xia, ZHANG Bin, GAO Binghua. Relationship between serum miR-326 and chemotherapy sensitivity and prognosis in patients with treatment-related hematological malignancy [J]. Laboratory Medicine, 2023, 38(3): 251-256.
[9]	HE Xin, LI Yanping. Influence of disease types and clinical indexes on the CMIA determination results of anti-HCV antibody [J]. Laboratory Medicine, 2023, 38(3): 287-290.
[10]	YU Tingting, WANG Jian. Progress and challenges in diagnosis and treatment of rare diseases [J]. Laboratory Medicine, 2023, 38(2): 103-105.
[11]	CAI Xiaoyi, LOU Dan, YANG Xingge, WANG Jian. Genetic analysis on 15 cases of suspected Duchenne muscular dystrophy/Becker muscular dystrophy [J]. Laboratory Medicine, 2023, 38(2): 106-111.
[12]	WANG Dongjiang, GUO Jian. Advance in laboratory diagnosis of invasive fungal infection [J]. Laboratory Medicine, 2023, 38(2): 179-185.
[13]	WANG Su, DING Li, JIANG Wenrong, MIAO Yingxin, ZHANG Yanmei, ZHAO Hu. Research progress on drug resistance and treatment strategies of hypervirulent Klebsiella pneumoniae [J]. Laboratory Medicine, 2023, 38(1): 81-86.
[14]	WEN Jing, SHI Rui, XIE Jia, LIU Feng, LI Guang, REN Jingjing, LEI Xiaoru, GUO Xiaobo, SONG Yanping. Clinical application of metagenomic next-generation sequencing for determining pathogens in febrile neutropenic patients [J]. Laboratory Medicine, 2022, 37(9): 855-859.
[15]	SUN Lei, LONG Ju, FAN Zuqian, WU Suping, LIN Guixian, LING Xiuming. sRapid determination of sex chromosome abnormality using double relative quantitative SD-qPCR [J]. Laboratory Medicine, 2022, 37(6): 557-560.